Biotage AB Acquires Rights to Novel Evaporation System from Vapourtec, Ltd

The purchase price for the deal consists of an up-front paymentand partial payments related to sales development. The total purchasecould reach at maximum 2,3 MGBP.

Commercial activities will begin immediately and sales for 2007are expected to reach between 5 to 10 MUSD.

"Evaporation presents a major bottleneck in chemistry and drugdevelopment. Vapourtec's V-10 substantially reduces sample drying timefor pharmaceutical chemists and fills this void in our product lines,"said Jeff Bork, Biotage AB CEO.

Duncan Guthrie, Vapourtec founder and CEO adds "Biotage was thelogical choice for partnering. They have large scale productionfacilities, a global sales and service presence and we intend to havean excellent relationship going forward on mutual developmentprograms."

"Evaporation is a technique employed immediately followingsynthesis and purification - so it is essential that Biotage offerthis technology. Vapourtec's V-10 was brought to our attention by someof our largest customers who participated in the product developmentphase. In addition to operating in batch mode at rates up to 40Xfaster than conventional evaporators, the Vapourtec product alsooperates in a continuous flow mode, which offers advantages notpossible with alternative designs," stated Dave Patteson, President ofBiotage's Discovery Chemistry Group.

About Biotage

Biotage is a global company active in life science research withstrong technologies, a broad range of operations and a long-term viewof the market. The company offers solutions, knowledge and experiencein the areas of genetic analysis and medicinal chemistry. Customersinclude the worlds top 30 pharmaceutical companies, 20 largest biotechcompanies and leading academic institutes. The company isheadquartered in Uppsala and has offices in the US, Japan, UK andseveral other European countries. Biotage has approx. 330 employeesand had pro-forma sales of approx. 500 MSEK in 2004. Biotage is listedon the Stockholm stock exchange. Website: www.biotage.com

------------------------------------------------------------------------

About Vapourtec Ltd.

Vapourtec is a research and technology company located close toCambridge, UK. Its strength is strong R&D focusing on the drugdiscovery and associated industries, with particular emphasis onmedicinal chemistry. Vapourtec works in close partnership with majorpharmaceutical companies, with the objective of converting innovativeprocesses into reliable instrumentation. This Agreement with Biotagegives Vapourtec the opportunity to concentrate on additional noveltechnologies of benefit to the pharmaceutical industry.

This information was brought to you by Waymakerhttp://www.waymaker.net